Bio-Techne Corp

Financials

1株当たり配当金 0.320.320.320.320.32 0.56 配当利回り（％） 0.280.370.390.450.62 3.54 配当性向（％） 36.8919.3118.1830.4869.57 -167.1

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

ニュース

All You Need to Know About Techne (TECH) Rating Upgrade to Buy

Should You Continue to Hold Bio-Techne Stock in Your Portfolio?

AI搭載ソフトウェアへの懸念でBio-Techne株が下落、TD Cowenは買い機会と判断

マイクロソフトのAI空間解析ツールへの懸念で10X Genomics株が下落

Bio-Techne stock falls on AI software concerns, TD Cowen sees buy opportunity

10X Genomics stock falls on Microsoft AI spatial tool concerns

ArgusがAI創薬ツールを評価しBio-Techne株の目標株価を引き上げ

Argus raises Bio-Techne stock price target on AI drug discovery tools

April McClain Delaney makes multiple stock transactions in Bio-Techne, BJ’s Wholesale, and C.H Robinson

Why Is Techne (TECH) Down 15.1% Since Last Earnings Report?

Tracking Ruane, Cunniff, & Goldfarb’s Portfolio – Q4 2025 Update (MUTF:SEQUX)

The CEO of a startup building robots for factories explains how US manufacturing is at a crossroads